Kopra Bio Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$9.1M
- Investors
-
20
Kopra Bio General Information
Description
Operator of a biological therapy platform intended for medical treatment. The company's platform uses engineered biological agents capable of selectively targeting diseased cells, reprogramming them to produce immune-stimulating factors and engage the body's own defenses, with features including selective delivery mechanisms, modulation of immune responses, integration with existing therapeutic strategies, and adaptability to research and clinical development, enabling the oncology and biomedical research market to explore approaches to treating aggressive diseases and potentially improve long-term therapeutic outcomes and patient responses.
Contact Information
Website
www.kopra.bioCorporate Office
- 2114 32nd Avenue
- San Francisco, CA 94116
- United States
Corporate Office
- 2114 32nd Avenue
- San Francisco, CA 94116
- United States
Kopra Bio Timeline
Kopra Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Early Stage VC | 16-Jun-2026 | $9.1M | Completed | Generating Revenue | ||
| 6. Accelerator/Incubator | 11-Dec-2025 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 30-Oct-2025 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 04-Jun-2025 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 10-Jan-2025 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 26-Sep-2024 | $500K | $500K | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Jan-2024 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Kopra Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kopra Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kopra Bio Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Chamaeleon | Venture Capital | Minority | ||
| UCSF Innovation Ventures | Venture Capital | Minority | ||
| Charles River Incubator Program | Accelerator/Incubator | |||
| Andreessen Horowitz | Venture Capital | Minority | ||
| Boutique Venture Partners | Venture Capital | Minority |
Kopra Bio FAQs
-
When was Kopra Bio founded?
Kopra Bio was founded in 2024.
-
Where is Kopra Bio headquartered?
Kopra Bio is headquartered in San Francisco, CA.
-
What is the size of Kopra Bio?
Kopra Bio has 10 total employees.
-
What industry is Kopra Bio in?
Kopra Bio’s primary industry is Biotechnology.
-
Is Kopra Bio a private or public company?
Kopra Bio is a Private company.
-
What is Kopra Bio’s current revenue?
The current revenue for Kopra Bio is .
-
How much funding has Kopra Bio raised over time?
Kopra Bio has raised $9.7M.
-
Who are Kopra Bio’s investors?
Chamaeleon, UCSF Innovation Ventures, Charles River Incubator Program, Andreessen Horowitz, and Boutique Venture Partners are 5 of 20 investors who have invested in Kopra Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
